BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32372673)

  • 21. Management of endocrine disease: GH excess: diagnosis and medical therapy.
    Andersen M
    Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.
    Potorac I; Petrossians P; Daly AF; Alexopoulou O; Borot S; Sahnoun-Fathallah M; Castinetti F; Devuyst F; Jaffrain-Rea ML; Briet C; Luca F; Lapoirie M; Zoicas F; Simoneau I; Diallo AM; Muhammad A; Kelestimur F; Nazzari E; Centeno RG; Webb SM; Nunes ML; Hana V; Pascal-Vigneron V; Ilovayskaya I; Nasybullina F; Achir S; Ferone D; Neggers SJ; Delemer B; Petit JM; Schöfl C; Raverot G; Goichot B; Rodien P; Corvilain B; Brue T; Schillo F; Tshibanda L; Maiter D; Bonneville JF; Beckers A
    Endocr Relat Cancer; 2016 Nov; 23(11):871-881. PubMed ID: 27649724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gigantism: a mystery explained].
    Beckers A
    Bull Mem Acad R Med Belg; 2002; 157(1-2):111-7; discussion 117-9. PubMed ID: 12371275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acromegalogigantism].
    Scheinmann P; Ducottet-Valdant MC; Meyer B; Luton JP; Paupe J; Vialatte J
    Ann Pediatr (Paris); 1977 Apr; 24(4):287-91. PubMed ID: 16211971
    [No Abstract]   [Full Text] [Related]  

  • 25. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
    Rix M; Laurberg P; Hoejberg AS; Brock-Jacobsen B
    Eur J Endocrinol; 2005 Aug; 153(2):195-201. PubMed ID: 16061823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current diagnosis and treatment of acromegaly].
    Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
    Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study.
    Tahara S; Murakami M; Kaneko T; Shimatsu A
    Endocr J; 2017 Jul; 64(7):735-747. PubMed ID: 28592706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modern approach to resistant acromegaly.
    Giustina A; di Filippo L; Uygur MM; Frara S
    Endocrine; 2023 May; 80(2):303-307. PubMed ID: 36790521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
    Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
    J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.
    Martín-Rodríguez JF; Muñoz-Bravo JL; Ibañez-Costa A; Fernandez-Maza L; Balcerzyk M; Leal-Campanario R; Luque RM; Castaño JP; Venegas-Moreno E; Soto-Moreno A; Leal-Cerro A; Cano DA
    Sci Rep; 2015 Nov; 5():16298. PubMed ID: 26549306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6'6" United States Marine Seeks Treatment for Gynecomastia Only to Learn It Is All in His Head.
    Young DB
    Mil Med; 2015 Dec; 180(12):e1290-2. PubMed ID: 26633678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary tumours: acromegaly.
    Chanson P; Salenave S; Kamenicky P; Cazabat L; Young J
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):555-74. PubMed ID: 19945023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acromegaly.
    Dineen R; Stewart PM; Sherlock M
    QJM; 2017 Jul; 110(7):411-420. PubMed ID: 26873451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
    Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
    Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acromegaly: clinical features at diagnosis.
    Vilar L; Vilar CF; Lyra R; Lyra R; Naves LA
    Pituitary; 2017 Feb; 20(1):22-32. PubMed ID: 27812777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of pituitary gigantism.
    Cunha C; Saraiva C; Canas Marques C; Duarte JS
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.